Purchases and Sales Made in Q3 2022 in Titan Pharmaceuticals Inc (TTNP)
This table provides information about the institutional ownership of Titan Pharmaceuticals Inc (TTNP) during Q3 2022. The information is specifically focused on institutions that hold shares of TITAN PHARMACEUTICALS INC.
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Oct 26, 2022
Q3 2022
|
Truist Financial Corp
|
BUY
|
- |
625KNew |
$331K - $14.1M
|
625K
$2.26M
|
|
Nov 15, 2022
Q3 2022
|
State Street Corp
Boston, MA |
BUY
|
- |
38.3KNew |
$20.3K - $865K
|
38.3K
$138K
|
|
Oct 19, 2022
Q3 2022
|
Fny Investment Advisers, LLC
|
BUY
|
- |
28KNew |
$14.9K - $633K
|
28K
$101K
|
|
Nov 14, 2022
Q3 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
13.1KNew |
$6.93K - $296K
|
13.1K
$47.2K
|
|
Nov 14, 2022
Q3 2022
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
7.03K+ 9.39% |
$3.73K - $159K
|
81.9K
$296K
|
|
Nov 14, 2022
Q3 2022
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
1.74K+ 2.79% |
$922 - $39.3K
|
64.1K
$231K
|
|
Nov 14, 2022
Q3 2022
|
Morgan Stanley
New York, NY |
BUY
|
- |
24+ 150.0% |
$12.7 - $542
|
40
$144
|
|
Mar 17, 2023
Q3 2022
|
American Portfolios Advisors
Holbrook, NY |
BUY
|
- |
23New |
$12.2 - $520
|
23
$83
|
|
Nov 15, 2022
Q3 2022
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 14, 2022
Q3 2022
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-6- 7.41% |
$3.18 - $136
|
75
$271
|
|
Nov 10, 2022
Q3 2022
|
Ubs Group Ag
|
SELL
|
- |
-15.8K- 58.52% |
$8.36K - $356K
|
11.2K
$40.3K
|
|
Nov 07, 2022
Q3 2022
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-34K- 54.55% |
$18K - $768K
|
28.3K
$102K
|
|
Nov 14, 2022
Q3 2022
|
Israel Englander
Millennium Management LLC | New York, Ny
|
SELL
|
- |
-45.6K- 72.32% |
$24.2K - $1.03M
|
17.5K
$63.1K
|
|
Nov 14, 2022
Q3 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-96K- 39.88% |
$50.9K - $2.17M
|
145K
$522K
|